"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...

New family of MCUs helps automakers shift to SDVs with a range of zonal and electrification architecturesCombines leading-edge core performance ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Multi-Year Renewal Ensures Continued Availability of Premium NBA-Branded Merchandise. FRANKLIN, TENNESSEE / ACCESS Newswire / March 12, 2025 / ...

Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security, and global markets, today announced the award of the Short/Medium Range Sub-Orbital ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK 12.03.2025 / 14:06 CET/CEST The issuer is solely responsible for ...

EpicQuest Education (EEIQ)announced that it received a delinquency notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC on March 5, 2025 indicating that ...

Rail Vision (RVSN) announced that on March 6, the company received a written notice from the Nasdaq Stock Market indicating that the company was not in compliance with Nasdaq Listing Rule 5550(a ...

Lottery.com (LTRY) received a notice from The Nasdaq Stock Market determining that as a result of the closing bid price of the Company’s common share being $1.00 or above for the last twenty ...

2-Year U.S. Treasury Note Continuous Contract $103.598 0.016 0.02% 5-Year U.S. Treasury Note Continuous Contract $108.000 0.094 0.09% 10-Year U.S. Treasury Note Continuous Contract $110.969 0.125 ...